Basic Materials: Chemicals - 2008
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Basic Materials: Chemicals - 2008

Donald Carson of Merrill Lynch captures the top spot for a sixth straight year, owing largely to his “incredibly in-depth knowledge of the agriculture space,” as one ­money manager puts it.

150x178donald-carson1.jpg


Donald Carson


Donald Carson Merrill Lynch


SECOND TEAM


Robert Koort Goldman Sachs


THIRD TEAM


P.J. Juvekar ­ Citi


RUNNERS-UP


Kevin McCarthy BofA ; Sergey Vasnetsov Barclays ; Jeffrey Zekauskas ­ JPMorgan


Donald Carson of Merrill Lynch captures the top spot for a sixth straight year, owing largely to his “incredibly in-depth knowledge of the agriculture space,” as one ­money manager puts it. Carson, 54, told investors in September 2007 that rising demand for fertilizers would lead to higher prices and profits, and he reiterated his buy recommendations on phosphates producer Mosaic Co. of Plymouth, Minnesota, and Potash Corp. of Saskatchewan. By mid-­September 2008 the stocks had outperformed the sector by 77.4 and 52.6 percentage points, respectively. Unranked last year, Robert Koort of Goldman, Sachs & Co. is in second place. The former four-time first-­teamer in the predecessor Chemicals/Specialty sector is “simply the best stock picker in the group,” according to one investor. In January, Koort urged clients to buy Praxair, the biggest producer of industrial ­gases in the Americas, at $76.68, ­citing the Danbury, ­Connecticut–based company’s stable earnings growth. By mid-­September the stock had gained 13.2 percent, rising to $86.80. P.J. Juvekar, who holds steady in third place, “provides the best weekly update of the chemical group,” says one supporter. The ­Citi analyst ­also recommended Praxair, but his call, in October 2007, was premature. The stock gained 14.1 percent by late December but gave back those gains — and more — in January before starting a new ascent; it was up 9.3 percent from Juvekar’s call through mid-­September.


Return to The Best Analysts of the Year


Return to Rankings


Gift this article